Simultaneous determination of cyclophosphamide, ifosfamide, doxorubicin, epirubicin and daunorubicin in human urine using high-performance liquid chromatography/electrospray ionization tandem mass spectrometry: Bioanalytical method validation

Rapid Communications in Mass Spectrometry

Volumn 22, Issue 17, 2008, Pages 2645-2659

  Sottani, Cristina ^a   Rinaldi, Paola ^a   Leoni, Emanuela ^a   Poggi, Guido ^a   Teragni, Cristina ^a   Delmonte, Angelo ^a   Minoia, Claudio ^a  

^a IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; DRUG PRODUCTS; ELECTROSPRAY IONIZATION; IONIZATION POTENTIAL; MASS SPECTROMETRY; POSITIVE IONS; QUALITY CONTROL;

BIOANALYTICAL METHODS; DAUNORUBICIN; DOXORUBICIN; EPIRUBICIN; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-ELECTROSPRAY IONIZATION TANDEM MASS SPECTROMETRY; HUMAN URINE; IFOSFAMIDE; REVERSED-PHASE HIGH PERFORMANCE; SIMULTANEOUS DETERMINATIONS;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 50649098300     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.3657     Document Type: Article

References (39)

1. Jakubowski M, Trzcinka-Ochocka M. J Occup Health. 2005; 47: 22. Review. DOI: 10.1539/joh.47.22
2. Sorsa M, Hämeilä M, Järviluoma E. Ann. N. Y. Acad. Sci. 2006; 1076: 628. DOI: 10.1196/annals.1371.008
3. Fransman W, Peelen S, Hilhorst S, Roeleveld N, Heederik D, Kromhout H. Ann. Occup. Hyg. 2007; 51: 231. DOI: 10.1093/annhyg/mc1081
4. Connor TH, Anderson RW, Sessink PJ, Spivey SM. Am. J. Health Syst. Pharm. 2002; 59: 68.
5. Sessink PJ, Boer KA, Scheefhals AP, Anzion RB, Bos RP. Int. Arch. Occup. Environ. Health 1992; 64: 105. DOI: 10.1097/01.ede.0000246827. 44093.c1
6. Minoia C, Turci R, Sottani C, Schiavi A, Perbellini L, Angeleri S, Draicchio F, Apostoli P. Rapid Commun. Mass Spectrom. 1998; 12: 1485.
7. Dranitsaris G, Johnston M, Poirier S, Schueller T, Milliken D, Green E, Zanke B. Oncol. Pharm. Pract. 2005; 11: 69. DOI: 10.1191/1078155205jp155oa
8. Fransman W, Vermeulen R, Kromhout H. Ann. Occup. Hyg. 2004; 48: 237. DOI: 10.1093/annhyg/meh017
9. Travis LB, Gospodarowicz M, Curtis RE, Clarke E, Andersson M, Glimelius B, Joensuu T, Lynch CF, van Leeuwen FE, Holowaty E, Storm H, Glimelius I, Pukkala E, Stovall M, Fraumeni JF Jr, Boice JD Jr, Gilbert E. J. Natl. Cancer Inst. 2002; 94: 182. DOI: 10.1093/jnci/94.3.182
10. Crump M, Tu D, Shepherd L, Levine M, Bramwell V, Pritchard K. J. Clin. Oncol. 2003; 21: 3066. DOI: 10.1200/jco.2003.08.137
11. Zagotto G, Gatto B, Moro S, Sissi C, Palumbo M. J. Chromatogr. B. Biomed. Sci. Appl. 2001; 764: 161. Review. DOI: 10.1016/s0378- 4347(01)00346-2
12. Stokvis E, Rosing H, Beijnen JH. Mass Spectrom Rev. 2005; 24: 887. Review. 13.
13. Turci R, Sottani C, Spagnoli G, Minoia C. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 2003; 789: 169. Review. DOI: 10.1016/s1570-0232(03)00100-4
14. Sottani C, Tranfo G, Bettinelli M, Faranda P, Spagnoli M, Minoia C. Rapid Commun. Mass Spectrom. 2004; 18: 2426. DOI: 10.1002/rcm.1642
15. Dodde WI, Maring JG, Hendriks G, Wachters FM, Groen HJ, de Vries EG, Uges DR. Ther. Drug Monit. 2003; 25: 433.
16. Lachâtre F, Marquet P, Ragot S, Gaulier JM, Cardot P, Dupuy JL. J. Chromatogr. B. Biomed. Sci. Appl. 2000; 738: 281.
17. Arnold RD, Slack JE, Straubinger RM. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 2004; 808: 141. DOI: 10.1016/j.jchromb. 2004.04.030
18. Wall R, McMahon G, Crown J, Clynes M, O'Connor R. Talanta 2007; 72: 145. DOI: 10.1016/j.talanta.2006.10.010
19. Turci R, Sottani C, Ronchi A, Minoia C. Toxicol. Lett. 2002; 134: 57. DOI: 10.1016/S0378-4274(02)00163-7
20. Sannolo N, Miraglia N, Biglietto M, Acampora A, Malorni A. J. Mass Spectrom. 1999; 34: 845.
21. de Jonge ME, van Dam SM, Hillebrand MJ, Rosing H, Huitema AD, Rodenhuis S, Beijnen JH. J. Mass Spectrom. 2004; 39: 262. DOI: 10.1002/jms.570
22. Kasel D, Jetter A, Harlfinger S, Gebhardt W, Fuhr U. Rapid Commun. Mass Spectrom. 2004; 18: 1472. DOI: 10.1002/rcm.1508
23. Silvertand LH, Vazvaei F, Weigl P, Rosing H, Hillebrand MJ, van Maanen MJ, Beijnen JH. Rapid Commun. Mass Spectrom. 2005; 19: 3673. DOI: 10.1002/rcm.2242
24. Pethran A, Schierl R, Hauff K, Grimm CH, Boos KS, Nowak D. Int. Arch. Occup. Environ. Health 2003; 76: 5. DOI: 10.1007/s00420-002-0383-8
25. Sottani C, Tranfo G, Faranda P, Minoia C. Rapid Commun. Mass Spectrom. 2005; 19: 2794. DOI: 10.1002/rcm.2116
26. Barbieri A, Nucci MC, Sabatini L, Risi A, Bolognesi C, Colacci A, Violante FS. Epidemiol. Prev. 2005; 29: 87. DOI: 10.1002/rcm.2527
27. International Agency for Research on Cancer. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Pharmaceutical Drugs. Lyon, France. Available: http://monographs.iarc.fr/
28. Guidance for industry: bioanalytical method validation, FDA, US Department of Health and Human Services. 2001. Available: http://www.fda.gov/ cder/guidance/4252fnl.pdf
29. Shah VP, Midha KK, Findlay JW, Hill HM, Hulse JD, McGilveray IJ, McKay G, Miller KJ, Patnaik RN, Powell ML, Tonelli A, Viswanathan CT, Yacobi A. Pharmaceut. Res. 2000; 17: 1551.
30. Matuszewski BK, Constanzer ML, Chavez-Eng CM. Anal. Chem. 2003; 75: 3019.
31. Matuszewski BK. J. Chromatogr. B 2006; 830: 293.
32. Available: http://www.measurementuncertainty.org/mu/QUAM2000-1.pdf
33. Shellens JHM, McLeod HL, Newell DR. Cancer Clinical Pharmacology. Oxford University Press: Oxford, 2005; 119.
34. Available: http://www.drugbank.com
35. Grung M, Heimstad ES, Moe M, Schlabach M, Svenson A, Thomas K, Woldegiorgis A. Report 2325, 2007; 31. Available: http://www.sft.no/ publikasjoner/2325/ta2325.pdf
36. Mallet CR, Lu Z, Mazzeo JR. Rapid Commun. Mass Spectrom. 2004; 18: 49. DOI: 10.1002/rcm.1276
37. Liu Z, Chan KK, Wang JJ. Rapid Commun. Mass Spectrom. 2005; 19: 2581. DOI: 10.1002/rcm.2099
38. Liu D, Hu P, Matsushima N, Li X, Li L, Jiang J. J. Chromatogr. B 2007; 856: 190. DOI: 10.1016/j.jchromb.2007.05.049
39. Provvedimento 5 agosto 1999. Documento di linee-guida per la sicurezza e la salute dei lavoratori esposti a chemioterapici antiblastici in ambiente sanitario Italian Guidelines G.U. 236, 7.10. 1999.